Free database of papers and journals






Results 1 to 20 of 37 articles found
1999

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

Lancet (9.3 902★★★), 353, 1568-1573.
2005

Conventional Disease-Modifying Antirheumatic Drugs in Early Arthritis

1987

Palindromic Rheumatism: A Clinical Survey of Sixty Patients

Scandinavian Journal of Rheumatology (1.8 92), 16, 413-420.
2011

Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000–2007

Scandinavian Journal of Rheumatology (1.8 92), 40, 16-21.
1987

Treatment of palindromic rheumatism with chloroquine.

2002

Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis

Arthritis and Rheumatism (365), 46, 894-898.
2017

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial

PloS One (2.7 366), 12, e0183294.
2004

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: Five-year experience from the FIN-RACo study

Arthritis and Rheumatism (365), 50, 2072-2081.
1993

Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study

Arthritis and Rheumatism (365), 36, 1501-1509.
2010

Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial

Arthritis Research & Therapy (4.2 134), 12, R122.
2005

How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience

2018

High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis

Clinical Rheumatology (2.6 89), 37, 1689-1694.
2009

The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial

Arthritis and Rheumatism (365), 60, 1222-1231.
2015

Impact of physicians’ adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial

Scandinavian Journal of Rheumatology (1.8 92), 44, 449-455.
1996

Outcome in patients with early rheumatoid arthritis treated according to the “sawtooth” strategy

Arthritis and Rheumatism (365), 39, 996-1005.
2014

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Annals of the Rheumatic Diseases (6.9 256★★), 73, 1954-1961.
2013

Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial

Annals of the Rheumatic Diseases (6.9 256★★), 72, 786-788.
1989

[Communication] Serum C1q level does not predict joint erosion in early rheumatoid arthritis

Arthritis and Rheumatism (365), 32, 511-512.
2015

Long-Term Real-Life Experience With Rituximab in Adult Finnish Patients With Rheumatoid Arthritis Refractory or With Contraindication to Anti–Tumor Necrosis Factor Drugs

Journal of Clinical Rheumatology (0.7 50), 21, 24-30.
2008

Combination drug strategy in recent‐onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression

Scandinavian Journal of Rheumatology (1.8 92), 37, 90-93.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions